These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8321364

  • 1. Comparative nephrotoxicity of tetraplatin and cisplatin in rats.
    Rahman A, Roh JK, Preuss HG.
    Nephron; 1993; 64(2):289-95. PubMed ID: 8321364
    [Abstract] [Full Text] [Related]

  • 2. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.
    Smith JH, Smith MA, Litterst CL, Copley MP, Uozumi J, Boyd MR.
    Fundam Appl Toxicol; 1988 Jan; 10(1):45-61. PubMed ID: 3350229
    [Abstract] [Full Text] [Related]

  • 3. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.
    Smith MA, Smith JH, Litterst CL, Copley MP, Uozumi J, Boyd MR.
    Fundam Appl Toxicol; 1988 Jan; 10(1):62-72. PubMed ID: 3350230
    [Abstract] [Full Text] [Related]

  • 4. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
    Carfagna PF, Chaney SG, Chang J, Holbrook DJ.
    Fundam Appl Toxicol; 1990 May; 14(4):706-19. PubMed ID: 2163338
    [Abstract] [Full Text] [Related]

  • 5. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation.
    Kawai Y, Taniuchi S, Okahara S, Nakamura M, Gemba M.
    Biol Pharm Bull; 2005 Aug; 28(8):1385-8. PubMed ID: 16079479
    [Abstract] [Full Text] [Related]

  • 6. Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices.
    Kameyama Y, Okazaki N, Nakagawa M, Koshida H, Nakamura M, Gemba M.
    Toxicol Lett; 1990 Jun; 52(1):15-24. PubMed ID: 2356567
    [Abstract] [Full Text] [Related]

  • 7. The nephrotoxicity, cytotoxicity and renal handling of a cisplatin-methionine complex in male Wistar rats.
    Deegan PM, Pratt IS, Ryan MP.
    Toxicology; 1994 Mar 25; 89(1):1-14. PubMed ID: 8178319
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV.
    Cancer Res; 1988 Apr 01; 48(7):1745-52. PubMed ID: 3162402
    [Abstract] [Full Text] [Related]

  • 9. Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats.
    Scott LA, Madan E, Valentovic MA.
    Toxicology; 1990 Apr 01; 60(1-2):109-25. PubMed ID: 2107603
    [Abstract] [Full Text] [Related]

  • 10. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Loh SY, Abel G, Murrer BA, Harrap KR.
    Cancer Res; 1992 Nov 15; 52(22):6188-93. PubMed ID: 1423261
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of the renal endoplasmic reticulum calcium pump: a possible biomarker for platinate toxicity.
    De Witt LM, Jones TW, Moore L.
    Toxicol Appl Pharmacol; 1988 Feb 15; 92(2):157-69. PubMed ID: 2963406
    [Abstract] [Full Text] [Related]

  • 12. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK, Kwon YE.
    Cancer Chemother Pharmacol; 2007 Jul 15; 60(2):237-43. PubMed ID: 17089165
    [Abstract] [Full Text] [Related]

  • 13. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
    Hannemann J, Baumann K.
    Arch Toxicol; 1990 Jul 15; 64(5):393-400. PubMed ID: 2169720
    [Abstract] [Full Text] [Related]

  • 14. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K, Asano K, Nishimura T, Chimata T, Matsuo Y, Tsuchiya M, Ogata H.
    J Pharm Pharmacol; 2008 Mar 15; 60(3):317-22. PubMed ID: 18284811
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats.
    Engineer MS, Brown NS, Ho DH, Newman RA, Bulger RE.
    Toxicology; 1989 Dec 01; 59(2):151-62. PubMed ID: 2588264
    [Abstract] [Full Text] [Related]

  • 17. Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat.
    McKeage MJ, Boxall FE, Jones M, Harrap KR.
    Cancer Res; 1994 Feb 01; 54(3):629-31. PubMed ID: 8306321
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys.
    Miura K, Goldstein RS, Pasino DA, Hook JB.
    Toxicology; 1987 May 30; 44(2):147-58. PubMed ID: 3564050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.